Bristol-Myers Squibb Company (BMY)
FlaggedUS listed · Healthcare · Drug Manufacturers - General
This page tracks Bristol-Myers Squibb Company (BMY) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews BMY against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Oct 2, 2026Screen strength 0.0The pre-screen STRONG_SELL at 0.03/10 is confirmed by a weak risk-adjusted profile: a Sharpe of 0.19 (poor) and modest 6.94% CAGR indicate the stock has underperformed its volatility over the past year. Price has broken below the SMA-50 ($64.51) and now trades at $60.35, with RSI at 39 suggesting further downside pressure before oversold conditions emerge. Recent high-volume selling (36.8M shares on 9/18, 15.8M on 9/29 and 9/30) on lower closes confirms distribution. The MACD remains negative with a widening histogram (-0.155), offering no near-term bullish catalyst. Macro headwinds (rising rates, fear sentiment) and weak revenue growth (3.1% TTM) despite strong EPS (99.3% YoY—likely driven by buybacks rather than operational leverage) further weaken the fundamental case. The 0.20 beta provides little defensive shelter.
BMY AI Signal Track Record
Recent scanner signals for Bristol-Myers Squibb Company. Each is a point-in-time AI assessment, not a guarantee of future performance.
| Date | Signal | Screen strength | Price at signal |
|---|---|---|---|
| Oct 2, 2026 | Flagged | 0.0 | $60.35 |
| Oct 1, 2026 | Flagged | 0.1 | $61.40 |
| Oct 1, 2026 | Flagged | 0.1 | $61.40 |
| Oct 1, 2026 | Flagged | 0.1 | $61.40 |
| Oct 1, 2026 | Flagged | 0.1 | $61.43 |
| Oct 1, 2026 | Flagged | 0.1 | $61.33 |
BMY — Frequently Asked Questions
Is Bristol-Myers Squibb Company (BMY) a buy right now?
As of October 2, 2026, StockTracker AI's screen flags BMY as Flagged, with a ±1.6% typical 3-day move, based on its multi-factor technical screen and AI review. This is a technical screen and informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is BMY's RSI?
BMY's 14-day RSI was 39.1 at the last scan — in neutral territory. RSI above 70 is generally considered overbought and below 30 oversold; the 40–60 band is neutral and is best read alongside trend and momentum rather than on its own.
What is the AI price forecast for BMY?
StockTracker AI generates a probability-weighted 30-day price forecast for BMY — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze BMY?
Each scan screens BMY on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for BMY — free.
Add BMY to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for BMY
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →